1. Home
  2. SEMR vs NVAX Comparison

SEMR vs NVAX Comparison

Compare SEMR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • NVAX
  • Stock Information
  • Founded
  • SEMR 2008
  • NVAX 1987
  • Country
  • SEMR United States
  • NVAX United States
  • Employees
  • SEMR N/A
  • NVAX N/A
  • Industry
  • SEMR EDP Services
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SEMR Technology
  • NVAX Health Care
  • Exchange
  • SEMR Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • SEMR 1.4B
  • NVAX 1.3B
  • IPO Year
  • SEMR 2021
  • NVAX 1995
  • Fundamental
  • Price
  • SEMR $9.33
  • NVAX $6.80
  • Analyst Decision
  • SEMR Buy
  • NVAX Buy
  • Analyst Count
  • SEMR 8
  • NVAX 5
  • Target Price
  • SEMR $17.00
  • NVAX $16.60
  • AVG Volume (30 Days)
  • SEMR 828.8K
  • NVAX 5.2M
  • Earning Date
  • SEMR 08-04-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • SEMR N/A
  • NVAX N/A
  • EPS Growth
  • SEMR N/A
  • NVAX N/A
  • EPS
  • SEMR 0.05
  • NVAX 2.97
  • Revenue
  • SEMR $396,021,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • SEMR $21.84
  • NVAX $56.85
  • Revenue Next Year
  • SEMR $18.46
  • NVAX N/A
  • P/E Ratio
  • SEMR $192.99
  • NVAX $2.29
  • Revenue Growth
  • SEMR 22.75
  • NVAX 25.92
  • 52 Week Low
  • SEMR $7.90
  • NVAX $5.01
  • 52 Week High
  • SEMR $18.74
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 44.22
  • NVAX 51.68
  • Support Level
  • SEMR $8.74
  • NVAX $6.23
  • Resistance Level
  • SEMR $9.18
  • NVAX $6.90
  • Average True Range (ATR)
  • SEMR 0.31
  • NVAX 0.30
  • MACD
  • SEMR 0.02
  • NVAX 0.01
  • Stochastic Oscillator
  • SEMR 64.29
  • NVAX 67.00

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: